Applications of ionic liquids in the chemical industry

|

article image
Applications of Ionic Liquids’’, a round table was held. It outlined, in detail, a strategy for the development of ionic liquids for industrial applications and set criteria that would have to be met:52  Ionic liquids are intrinsically interesting and worthy of study for advancing with the expectation.

Spotlight

La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La Jolla’s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension. LJPC-401 is La Jolla’s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is our next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.

OTHER ARTICLES

Petrochemicals in PA: What You Need to Know

Article | February 19, 2020

A bill recently passed by the Pennsylvania General Assembly would subsidize the use of fracked gas to produce petrochemicals. At some point—i.e., at a time chosen by the state Senate—H B 1100 will be sent to Governor Wolf, who has promised a veto despite override threats. Meanwhile, Pennsylvanians are trying to understand the bill and its potential impacts. That hasn't been easy, because as with the petrochemical subsidy bills Pennsylvania enacted in 2012, the General Assembly has not held a single hearing on the legislation. The purpose of this blog is to help fill that gap.

Read More

Eliminating Harmful Chemicals from Your Household Products

Article | February 19, 2020

I have just recently starting swapping out my old household cleaning products for new, safer versions that contain fewer harmful chemicals. This can be a daunting process for most people including me! I am by no means an expert in this process, and I have debated whether I should write a blog article about it. However, I decided to go ahead and share with you what I have learned so far, and maybe we can go through this process together.

Read More

What is Rate of Reaction and Why is It Important For The Chemical Industry?

Article | February 19, 2020

It would not be an exaggeration to say that the rate of reaction is the true lifeline of the chemical industry in India, and the whole world. A lower rate of reaction would mean, chemical manufacturers can produce products at much faster rates which gives them a great competitive advantage over others. The chemical industry strives to create a faster rate of reactions as it impacts revenue goals.

Read More

What Are Fine Chemicals?

Article | February 19, 2020

The initial versions of drugs were produced by extracting substances from natural herbs and other plants. As understanding and technology in chemistry continued to grow, scientists figured out to isolate and extract a lot more individual compounds from raw materials. The complicated processes that produce these simple, pure substances form the field of fine chemistry. The chemical industry is separated into branches, with fine chemicals serving as the smallest segment of them. Its companions are commodities and specialty chemicals. Commodity chemicals are those that are mass-produced on a big scale to supply global markets. They include general compounds that are the same from supplier to supplier. Specialty chemicals usually are sold as brand name products and are advertised for their distinct qualities and their abilities to carry out functions that other chemicals cannot. They are composed of one or more fine chemicals.

Read More

Spotlight

La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases. The Company has several product candidates in development. LJPC-501 is La Jolla’s proprietary formulation of angiotensin II for the potential treatment of catecholamine-resistant hypotension. LJPC-401 is La Jolla’s novel formulation of hepcidin for the potential treatment of conditions characterized by iron overload, such as hereditary hemochromatosis, beta thalassemia, sickle cell disease and myelodysplastic syndrome. LJPC-30S is our next-generation gentamicin derivative program that is focused on therapeutics for the potential treatment of serious bacterial infections as well as rare genetic disorders, such as cystic fibrosis and Duchenne muscular dystrophy.

Events